Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2025-02-14

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.5bn reported value -23.7% vs Q3 2024
37positions
70.5%in top 10
3 new 5 added 10 reduced 4 sold out vs Q3 2024

Holdings, Q4 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APOGEE THERAPEUTICS INC COM COM 8,493,321 $384.7m26.40% 26.40% UnchangedShares held: Q1 2024 8.5m, Q2 2024 8.5m, Q3 2024 8.5m, Q4 2024 8.5m
2 OCULAR THERAPEUTIX INC COM OCUL OCUL 12,762,462 $109.0m7.48% 7.48% UnchangedShares held: Q1 2024 12.8m, Q2 2024 12.8m, Q3 2024 12.8m, Q4 2024 12.8m
3 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 4,026,331 $90.6m6.22% 6.22% UnchangedShares held: Q1 2024 4.0m, Q2 2024 4.0m, Q3 2024 4.0m, Q4 2024 4.0m
4 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 989,985 $76.2m5.23% 5.23% AddedShares held: Q1 2024 706.1k, Q2 2024 706.1k, Q3 2024 706.1k, Q4 2024 990.0k +283.9k +283,854 40.2%
5 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 3,882,709 $74.4m5.11% 5.11% UnchangedShares held: Q1 2024 3.9m, Q2 2024 3.9m, Q3 2024 3.9m, Q4 2024 3.9m
6 ORUKA THERAPEUTICS INC COM ORKA ORKA 3,285,620 $63.7m4.37% 4.37% AddedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 3.1m, Q4 2024 3.3m +200.0k +200,000 6.5%
7 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 2,685,448 $62.5m4.29% 4.29% UnchangedShares held: Q1 2024 2.2m, Q2 2024 2.7m, Q3 2024 2.7m, Q4 2024 2.7m
8 PHARVARIS N V COM PHVS PHVS 3,220,130 $61.7m4.24% 4.24% ReducedShares held: Q1 2024 3.4m, Q2 2024 3.4m, Q3 2024 3.4m, Q4 2024 3.2m -175.5k -175,476 -5.2%
9 KALVISTA PHARMACEUTICALS INC COM KALV KALV 6,249,731 $52.9m3.63% 3.63% UnchangedShares held: Q1 2024 6.2m, Q2 2024 6.2m, Q3 2024 6.2m, Q4 2024 6.2m
10 DYNE THERAPEUTICS INC COM DYN DYN 2,173,913 $51.2m3.51% 3.51% UnchangedShares held: Q1 2024 2.2m, Q2 2024 2.2m, Q3 2024 2.2m, Q4 2024 2.2m
11 COGENT BIOSCIENCES INC COM COGT COGT 5,684,411 $44.3m3.04% 3.04% AddedShares held: Q1 2024 5.1m, Q2 2024 5.7m, Q3 2024 5.7m, Q4 2024 5.7m +244 +244 0.0%
12 ERASCA INC COM ERAS ERAS 16,216,216 $40.7m2.79% 2.79% UnchangedShares held: Q1 2024 0, Q2 2024 16.2m, Q3 2024 16.2m, Q4 2024 16.2m
13 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 1,744,373 $38.0m2.61% 2.61% UnchangedShares held: Q1 2024 2.1m, Q2 2024 2.1m, Q3 2024 1.7m, Q4 2024 1.7m
14 UPSTREAM BIO INC COM UPB UPB 2,295,319 $37.7m2.59% 2.59% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 2.3m
15 ORIC PHARMACEUTICALS INC COM ORIC ORIC 4,394,527 $35.5m2.43% 2.43% UnchangedShares held: Q1 2024 4.4m, Q2 2024 4.4m, Q3 2024 4.4m, Q4 2024 4.4m
16 ENGENE HOLDINGS INC COM COM 5,046,414 $33.6m2.30% 2.30% AddedShares held: Q1 2024 2.6m, Q2 2024 2.8m, Q3 2024 3.6m, Q4 2024 5.0m +1.5m +1,480,573 41.5%
17 MERUS N V COM MRUS MRUS 592,411 $24.9m1.71% 1.71% ReducedShares held: Q1 2024 1.8m, Q2 2024 1.3m, Q3 2024 908.0k, Q4 2024 592.4k -315.6k -315,552 -34.8%
18 ASTRIA THERAPEUTICS INC COM CATB CATB 2,457,348 $22.0m1.51% 1.51% ReducedShares held: Q1 2024 3.6m, Q2 2024 3.6m, Q3 2024 3.5m, Q4 2024 2.5m -1.0m -1,001,297 -28.9%
19 CIDARA THERAPEUTICS INC COM NEW CDTX CDTX 765,723 $20.6m1.41% 1.41% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 765.7k
20 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,379,965 $16.8m1.15% 1.15% UnchangedShares held: Q1 2024 0, Q2 2024 1.4m, Q3 2024 1.4m, Q4 2024 1.4m
21 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 2,952,371 $16.4m1.13% 1.13% ReducedShares held: Q1 2024 4.4m, Q2 2024 4.4m, Q3 2024 4.4m, Q4 2024 3.0m -1.4m -1,447,629 -32.9%
22 ARTIVA BIOTHERAPEUTICS INC COM ARTV ARTV 1,609,569 $16.2m1.11% 1.11% UnchangedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 1.6m, Q4 2024 1.6m
23 MERSANA THERAPEUTICS INC COM COM 10,257,790 $14.7m1.01% 1.01% ReducedShares held: Q1 2024 11.3m, Q2 2024 11.3m, Q3 2024 11.3m, Q4 2024 10.3m -1.1m -1,070,210 -9.4%
24 ABIVAX SA SPONSORED ADS ABVX ABVX 1,345,780 $9.9m0.68% 0.68% UnchangedShares held: Q1 2024 1.3m, Q2 2024 1.3m, Q3 2024 1.3m, Q4 2024 1.3m
25 AQUESTIVE THERAPEUTICS INC COM AQST AQST 2,629,786 $9.4m0.64% 0.64% ReducedShares held: Q1 2024 5.6m, Q2 2024 5.6m, Q3 2024 5.6m, Q4 2024 2.6m -2.9m -2,925,769 -52.7%
26 APPLIED THERAPEUTICS INC COM APLT APLT 9,990,591 $8.6m0.59% 0.59% AddedShares held: Q1 2024 9.1m, Q2 2024 9.5m, Q3 2024 9.8m, Q4 2024 10.0m +165.6k +165,591 1.7%
27 PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS FRNM FRNM 750,000 $7.6m0.52% 0.52% UnchangedShares held: Q1 2024 0, Q2 2024 750.0k, Q3 2024 750.0k, Q4 2024 750.0k
28 TERNS PHARMACEUTICALS INC COM COM 1,077,090 $6.0m0.41% 0.41% ReducedShares held: Q1 2024 3.4m, Q2 2024 3.4m, Q3 2024 3.4m, Q4 2024 1.1m -2.3m -2,332,968 -68.4%
29 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 3,225,180 $5.6m0.38% 0.38% ReducedShares held: Q1 2024 9.0m, Q2 2024 9.0m, Q3 2024 9.0m, Q4 2024 3.2m -5.8m -5,774,820 -64.2%
30 TREVI THERAPEUTICS INC COM TRVI TRVI 1,266,457 $5.2m0.36% 0.36% ReducedShares held: Q1 2024 3.4m, Q2 2024 3.4m, Q3 2024 3.4m, Q4 2024 1.3m -2.2m -2,156,199 -63.0%
31 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 2,023,166 $5.1m0.35% 0.35% UnchangedShares held: Q1 2024 0, Q2 2024 6.0m, Q3 2024 2.0m, Q4 2024 2.0m
32 CENTURY THERAPEUTICS INC COM IPSC IPSC 3,957,186 $4.0m0.27% 0.27% ReducedShares held: Q1 2024 3.4m, Q2 2024 5.4m, Q3 2024 5.4m, Q4 2024 4.0m -1.4m -1,432,073 -26.6%
33 CASI PHARMACEUTICALS INC ORD SHS CASIF CASIF 987,259 $2.8m0.19% 0.19% UnchangedShares held: Q1 2024 0, Q2 2024 111.7k, Q3 2024 987.3k, Q4 2024 987.3k
34 TENAYA THERAPEUTICS INC COM TNYA TNYA 1,555,556 $2.2m0.15% 0.15% UnchangedShares held: Q1 2024 1.6m, Q2 2024 1.6m, Q3 2024 1.6m, Q4 2024 1.6m
35 TENAX THERAPEUTICS INC COM NEW TENX TENX 208,333 $1.3m0.09% 0.09% UnchangedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 208.3k, Q4 2024 208.3k
36 GLYCOMIMETICS INC COM COM 3,000,000 $747.0k0.05% 0.05% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 3.0m
37 INSTIL BIO INC COM NEW TIL TIL 33,177 $633.3k0.04% 0.04% UnchangedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 33.2k, Q4 2024 33.2k

Sold out since Q3 2024

SecurityTickerShares held beforeValue then
EDGEWISE THERAPEUTICS INC EWTX EWTX 1,000,000 $26.7m1.0m shares
ARVINAS INC ARVN ARVN 454,450 $11.2m454.4k shares
ADVERUM BIOTECHNOLOGIES INC ADVM ADVM 1,467,048 $10.3m1.5m shares
CABALETTA BIO INC CABA CABA 1,563,952 $7.4m1.6m shares